Core-binding Factor Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Core-binding Factor Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML [Phase 4]
Phase 4 trial comparing fludarabine plus cytarabine versus high-dose cytarabine in core-binding factor acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Avapritinib in CBF-AML With KIT Mutations [Phase 2]
Phase 2 clinical trial update for Avapritinib in Core Binding Factor Acute Myeloid Leukemia with KIT mutations.
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML [Phase 2]
Phase 2 clinical trial evaluating the combination of sorafenib with standard therapy in newly diagnosed adult Core Binding Factor Acute Myel…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial assessing combination chemotherapy with dasatinib for newly diagnosed acute myeloid leukemia; completed with results …